Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Convatec hires former Fortrea, Labcorp and GSK exec as CFO

3rd Nov 2026 09:59

Convatec Group PLC - London-based medical products, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care - Hires Jill McConnell to be chief financial officer, replacing Fiona Ryder. McConnell will join the company on January 1 and take over as CFO and board director on March 1 after the release of Convatec's 2026 results on February 23. Convatec notes that McConnell brings more than 25 years of finance experience, most recently serving as CFO of New York-listed clinical research firm Fortrea Holdings Inc, with previous senior roles at Labcorp Holdings Inc and GSK PLC. At Convatec, McConnell will lead Finance, Corporate Strategy & Development, Convatec Business Services and Investor Relations, reporting to Chief Executive Officer Jonny Mason. Back in July, Convatec had said Ryder would step down as CFO, having been in post since the start of 2022.

Additionally on Tuesday, Convatec promotes Brian May to senior independent director, succeeding Margaret Ewing, who will remain on the board until the company's next annual general meeting, which it holds in May.

Convatec will provide a trading update on November 18.

Current stock price: 244.00 pence, down 0.7% on Tuesday morning in London

12-month change: up 2.2%

By Tom Waite, Alliance News editor

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

ConvaTecGlaxosmithkline
FTSE 100 Latest
Value10,829.21
Change190.78